FDA Authorizes Bivalent Vaccines, Students React
By: Milena Mata | Contributor mm1934@jagmail.southalabama.edu On August 31, 2022, the FDA authorized the Pfizer-BioNTech and Moderna bivalent vaccines. They target both BA.4 and BA.5 Omicron variants of the virus. According to the CDC, the bivalent vaccines replace the need to get the previous boosters. The FDA recommends the Pfizer-BioNTech booster for people ages 12 and older and the Moderna booster for those ages 18 … Continue reading FDA Authorizes Bivalent Vaccines, Students React
